Palisade Bio Inc (PALI)
$4.42
Insights on Palisade Bio Inc
Vs NVO
In the last 3 years, Novo Nordisk A/s has given 235.1% return, outperforming this stock by 332.6%
Performance
- $4.30$4.72$4.42
2.71%
Downside
Day's Volatility :8.9%
Upside
6.36%
- $3.82$36.60$4.42
13.57%
Downside
52 Weeks Volatility :89.56%
Upside
87.92%
Returns
| Period | Palisade Bio Inc | Index (Russel 2000) |
|---|---|---|
3 Months | -21.27% | 0.0% |
6 Months | 610.29% | 0.0% |
1 Year | 230.99% | 0.0% |
3 Years | -97.51% | -22.6% |
Highlights
Market Capitalization | 4.5M |
Book Value | $11.82 |
Earnings Per Share (EPS) | -23.17 |
Wall Street Target Price | 33.75 |
Profit Margin | 0.0% |
Operating Margin TTM | 0.0% |
Return On Assets TTM | -62.64% |
Return On Equity TTM | -113.28% |
Revenue TTM | 0.0 |
Revenue Per Share TTM | 0.0 |
Quarterly Revenue Growth YOY | 0.0% |
Gross Profit TTM | 0.0 |
EBITDA | -14.0M |
Diluted Eps TTM | -23.17 |
Quarterly Earnings Growth YOY | 0.0 |
EPS Estimate Current Year | -11.65 |
EPS Estimate Next Year | -8.81 |
EPS Estimate Current Quarter | -4.8 |
EPS Estimate Next Quarter | -4.5 |
Analyst Recommendation
- Current
- 1M Ago
- 3M Ago
Analyst Forecast
What analysts predicted
Upside of 663.57%
Technicals Summary
Sell
Neutral
Buy
Palisade Bio Inc is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.
Peers
| Company Name | 1 Month | 6 Month | 1 Year | 3 Years | 5 Years |
|---|---|---|---|---|---|
 Palisade Bio Inc | -44.44% | 610.29% | 230.99% | -97.51% | -99.08% |
 Moderna, Inc. | 19.0% | 85.08% | 12.75% | -28.27% | 721.13% |
 Regeneron Pharmaceuticals, Inc. | 3.22% | 20.54% | 31.88% | 92.14% | 229.83% |
 Novo Nordisk A/s | 8.85% | 36.12% | 71.83% | 234.04% | 457.53% |
 Vertex Pharmaceuticals Incorporated | 16.81% | 32.76% | 40.6% | 124.79% | 171.36% |
| Company Name | P/E Ratio | P/B Ratio | PEG Ratio | EPS | ROE | ROA | Div Yield | BVPS |
|---|---|---|---|---|---|---|---|---|
Palisade Bio Inc | 13.86 | NA | NA | -11.65 | -1.13 | -0.63 | NA | 11.82 |
Moderna, Inc. | 24.73 | NA | 0.0 | -7.14 | -0.38 | -0.16 | NA | 33.47 |
Regeneron Pharmaceuticals, Inc. | 28.89 | 28.89 | 1.46 | 44.13 | 0.15 | 0.08 | NA | 250.15 |
Novo Nordisk A/s | 46.97 | 46.97 | 2.36 | 3.5 | 1.0 | 0.25 | 0.01 | 22.18 |
Vertex Pharmaceuticals Incorporated | 29.59 | 29.59 | 0.53 | 17.08 | 0.24 | 0.13 | NA | 71.8 |
| Company Name | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin |
|---|---|---|---|---|---|
Palisade Bio Inc | Buy | $4.5M | -99.08% | 13.86 | 0.0% |
Moderna, Inc. | Buy | $54.6B | 721.13% | 24.73 | -115.82% |
Regeneron Pharmaceuticals, Inc. | Buy | $108.0B | 229.83% | 28.89 | 29.45% |
Novo Nordisk A/s | Buy | $602.6B | 457.53% | 46.97 | 36.55% |
Vertex Pharmaceuticals Incorporated | Buy | $117.5B | 171.36% | 29.59 | 39.46% |
Institutional Holdings
Vanguard Group Inc
0.48%Renaissance Technologies Corp
0.39%Geode Capital Management, LLC
0.25%State Street Corporation
0.16%Warberg Asset Management LLC
0.07%UBS Group AG
0.02%
Company Information
Organization | Palisade Bio Inc |
Employees | 9 |
CEO | Mr. J. D. Finley |
Industry | Miscellaneous |
Discover More
A Spac I Acquisition Corp
$4.42
-5.96%
Keyarch Acquisition Corp
$4.42
-5.96%
Connexa Sports Technologies Inc
$4.42
-5.96%
Us Value Etf
$4.42
-5.96%
First Wave Biopharma Inc
$4.42
-5.96%
Global X Msci Next Emerging
$4.42
-5.96%
Fat Projects Acquisition Corp
$4.42
-5.96%
Capital Link Global Fintech
$4.42
-5.96%
Applied Uv Inc
$4.42
-5.96%